HEADER TRANSFERASE 30-DEC-10 3Q60 TITLE CRYSTAL STRUCTURE OF VIRULENT ALLELE ROP5B PSEUDOKINASE DOMAIN BOUND TITLE 2 TO ATP COMPND MOL_ID: 1; COMPND 2 MOLECULE: ROP5B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PSEUDOKINASE DOMAIN; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TOXOPLASMA GONDII; SOURCE 3 ORGANISM_TAXID: 5811; SOURCE 4 STRAIN: RH; SOURCE 5 GENE: ROP5B;TGGT1_042710; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS PSEUDOKINASE, TOXOPLASMA, TRANSFERASE, 551.M00238, ROP5 EXPDTA X-RAY DIFFRACTION AUTHOR M.L.REESE,J.C.BOOTHROYD REVDAT 2 22-FEB-12 3Q60 1 JRNL VERSN REVDAT 1 23-FEB-11 3Q60 0 JRNL AUTH M.L.REESE,J.C.BOOTHROYD JRNL TITL A CONSERVED NON-CANONICAL MOTIF IN THE PSEUDOACTIVE SITE OF JRNL TITL 2 THE ROP5 PSEUDOKINASE DOMAIN MEDIATES ITS EFFECT ON JRNL TITL 3 TOXOPLASMA VIRULENCE. JRNL REF J.BIOL.CHEM. V. 286 29366 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21708941 JRNL DOI 10.1074/JBC.M111.253435 REMARK 2 REMARK 2 RESOLUTION. 1.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.22 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 39069 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1958 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.2236 - 3.7025 1.00 4063 214 0.1784 0.1894 REMARK 3 2 3.7025 - 2.9396 1.00 3902 205 0.1696 0.1921 REMARK 3 3 2.9396 - 2.5683 1.00 3830 201 0.1710 0.2055 REMARK 3 4 2.5683 - 2.3335 1.00 3831 203 0.1699 0.2212 REMARK 3 5 2.3335 - 2.1663 0.99 3773 198 0.1737 0.2111 REMARK 3 6 2.1663 - 2.0386 0.99 3778 198 0.1795 0.2236 REMARK 3 7 2.0386 - 1.9366 0.98 3726 197 0.1848 0.2431 REMARK 3 8 1.9366 - 1.8523 0.97 3664 191 0.1942 0.2559 REMARK 3 9 1.8523 - 1.7810 0.93 3495 186 0.2237 0.2886 REMARK 3 10 1.7810 - 1.7200 0.81 3049 165 0.2613 0.3335 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.89 REMARK 3 K_SOL : 0.42 REMARK 3 B_SOL : 48.46 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.07620 REMARK 3 B22 (A**2) : 5.48840 REMARK 3 B33 (A**2) : -4.41220 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.00000 REMARK 3 B23 (A**2) : -0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.017 2841 REMARK 3 ANGLE : 1.707 3864 REMARK 3 CHIRALITY : 0.115 443 REMARK 3 PLANARITY : 0.009 492 REMARK 3 DIHEDRAL : 14.352 1050 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3Q60 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JAN-11. REMARK 100 THE RCSB ID CODE IS RCSB063237. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUL-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI(111) SIDE SCATTERING BENT REMARK 200 CUBE-ROOT I-BEAM SINGLE CRYSTAL, REMARK 200 ASYMMETRIC CUT 4.965 DEGS REMARK 200 OPTICS : RH COATED FLAT MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40071 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.720 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 13.900 REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.72 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.30 REMARK 200 R MERGE FOR SHELL (I) : 0.54000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG-3350, 0.3M SODIUM MALONATE, REMARK 280 0.02M MGCL2, 0.01M ATP, PH 5.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 61.67900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.66450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 61.67900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.66450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 631 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 632 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 171 REMARK 465 SER A 172 REMARK 465 HIS A 173 REMARK 465 MET A 174 REMARK 465 GLU A 175 REMARK 465 GLU A 292 REMARK 465 SER A 293 REMARK 465 PRO A 294 REMARK 465 GLU A 295 REMARK 465 GLU A 296 REMARK 465 ALA A 297 REMARK 465 ARG A 298 REMARK 465 ASP A 299 REMARK 465 ARG A 300 REMARK 465 ARG A 301 REMARK 465 GLN A 325 REMARK 465 ASP A 326 REMARK 465 ASP A 327 REMARK 465 THR A 539 REMARK 465 GLY A 540 REMARK 465 GLN A 541 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 217 -102.22 -103.00 REMARK 500 ALA A 219 -11.21 68.79 REMARK 500 GLN A 229 39.14 34.36 REMARK 500 PHE A 318 -31.82 79.67 REMARK 500 ASP A 407 70.70 53.76 REMARK 500 LEU A 459 -48.09 74.36 REMARK 500 LEU A 507 30.33 -97.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 602 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ATP A 600 O2A REMARK 620 2 HOH A 611 O 84.4 REMARK 620 3 HOH A 612 O 98.3 89.3 REMARK 620 4 ASP A 407 OD1 174.2 90.3 84.0 REMARK 620 5 HOH A 644 O 93.4 175.0 95.5 91.7 REMARK 620 6 HOH A 608 O 90.9 87.0 169.7 86.4 88.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 603 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ATP A 600 O1A REMARK 620 2 ATP A 600 O3G 89.5 REMARK 620 3 ASP A 393 OD2 95.0 87.5 REMARK 620 4 ATP A 600 O2B 89.5 86.2 172.3 REMARK 620 5 HOH A 610 O 94.3 175.2 95.1 90.8 REMARK 620 6 HOH A 615 O 173.8 85.7 88.8 86.2 90.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MLI A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 603 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3Q5Z RELATED DB: PDB REMARK 900 SAME PROTEIN, APO FORM REMARK 999 REMARK 999 SEQUENCE REMARK 999 GENOMIC SEQUENCE ENCODING THE PROTEIN HAS BEEN DEPOSITED IN GENBANK REMARK 999 ACCESSION HQ916448. DBREF 3Q60 A 171 541 PDB 3Q60 3Q60 171 541 SEQRES 1 A 371 GLY SER HIS MET GLU ALA GLY ASP SER PHE MET ARG ASP SEQRES 2 A 371 LEU LEU LYS ARG GLU GLU GLU LEU ILE GLY TYR CYS ARG SEQRES 3 A 371 GLU GLU ALA LEU LYS GLU PRO ALA ALA MET VAL GLU ALA SEQRES 4 A 371 VAL THR ALA THR VAL TRP PRO GLN ASN ALA GLU THR THR SEQRES 5 A 371 VAL ASP SER LEU LEU SER GLN GLY GLU ARG LYS LEU LYS SEQRES 6 A 371 LEU VAL GLU PRO LEU ARG VAL GLY ASP ARG SER VAL VAL SEQRES 7 A 371 PHE LEU VAL ARG ASP VAL GLU ARG LEU GLU ASP PHE ALA SEQRES 8 A 371 LEU LYS VAL PHE THR MET GLY ALA GLU ASN SER ARG SER SEQRES 9 A 371 GLU LEU GLU ARG LEU HIS GLU ALA THR PHE ALA ALA ALA SEQRES 10 A 371 ARG LEU LEU GLY GLU SER PRO GLU GLU ALA ARG ASP ARG SEQRES 11 A 371 ARG ARG LEU LEU LEU PRO SER ASP ALA VAL ALA VAL GLN SEQRES 12 A 371 SER GLN PRO PRO PHE ALA GLN LEU SER PRO GLY GLN ASP SEQRES 13 A 371 ASP TYR ALA VAL ALA ASN TYR LEU LEU LEU MET PRO ALA SEQRES 14 A 371 ALA SER VAL ASP LEU GLU LEU LEU PHE SER THR LEU ASP SEQRES 15 A 371 PHE VAL TYR VAL PHE ARG GLY ASP GLU GLY ILE LEU ALA SEQRES 16 A 371 LEU HIS ILE LEU THR ALA GLN LEU ILE ARG LEU ALA ALA SEQRES 17 A 371 ASN LEU GLN SER LYS GLY LEU VAL HIS GLY HIS PHE THR SEQRES 18 A 371 PRO ASP ASN LEU PHE ILE MET PRO ASP GLY ARG LEU MET SEQRES 19 A 371 LEU GLY ASP VAL SER ALA LEU TRP LYS VAL GLY THR ARG SEQRES 20 A 371 GLY PRO ALA SER SER VAL PRO VAL THR TYR ALA PRO ARG SEQRES 21 A 371 GLU PHE LEU ASN ALA SER THR ALA THR PHE THR HIS ALA SEQRES 22 A 371 LEU ASN ALA TRP GLN LEU GLY LEU SER ILE TYR ARG VAL SEQRES 23 A 371 TRP CYS LEU PHE LEU PRO PHE GLY LEU VAL THR PRO GLY SEQRES 24 A 371 ILE LYS GLY SER TRP LYS ARG PRO SER LEU ARG VAL PRO SEQRES 25 A 371 GLY THR ASP SER LEU ALA PHE GLY SER CYS THR PRO LEU SEQRES 26 A 371 PRO ASP PHE VAL LYS THR LEU ILE GLY ARG PHE LEU ASN SEQRES 27 A 371 PHE ASP ARG ARG ARG ARG LEU LEU PRO LEU GLU ALA MET SEQRES 28 A 371 GLU THR PRO GLU PHE LEU GLN LEU GLN ASN GLU ILE SER SEQRES 29 A 371 SER SER LEU SER THR GLY GLN HET ATP A 600 31 HET MLI A 601 7 HET MG A 602 1 HET MG A 603 1 HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM MLI MALONATE ION HETNAM MG MAGNESIUM ION FORMUL 2 ATP C10 H16 N5 O13 P3 FORMUL 3 MLI C3 H2 O4 2- FORMUL 4 MG 2(MG 2+) FORMUL 6 HOH *276(H2 O) HELIX 1 1 GLY A 177 GLU A 188 1 12 HELIX 2 2 GLU A 188 LEU A 200 1 13 HELIX 3 3 PRO A 203 TRP A 215 1 13 HELIX 4 4 ASN A 271 GLY A 291 1 21 HELIX 5 5 LEU A 344 VAL A 354 1 11 HELIX 6 6 ARG A 358 LYS A 383 1 26 HELIX 7 7 THR A 391 ASP A 393 5 3 HELIX 8 8 ASP A 407 SER A 409 5 3 HELIX 9 9 SER A 421 VAL A 423 5 3 HELIX 10 10 PRO A 424 ALA A 428 5 5 HELIX 11 11 PRO A 429 ASN A 434 1 6 HELIX 12 12 THR A 441 LEU A 459 1 19 HELIX 13 13 PRO A 496 LEU A 507 1 12 HELIX 14 14 LEU A 516 MET A 521 1 6 HELIX 15 15 THR A 523 SER A 538 1 16 SHEET 1 A 7 GLU A 220 SER A 225 0 SHEET 2 A 7 GLU A 231 VAL A 242 -1 O ARG A 232 N VAL A 223 SHEET 3 A 7 SER A 246 ASP A 253 -1 O LEU A 250 N GLU A 238 SHEET 4 A 7 GLU A 258 THR A 266 -1 O GLU A 258 N ASP A 253 SHEET 5 A 7 VAL A 330 MET A 337 -1 O MET A 337 N ALA A 261 SHEET 6 A 7 ASP A 308 VAL A 312 -1 N VAL A 310 O LEU A 334 SHEET 7 A 7 GLU A 220 SER A 225 -1 N ASP A 224 O ALA A 311 SHEET 1 B 3 VAL A 342 ASP A 343 0 SHEET 2 B 3 LEU A 395 ILE A 397 -1 O ILE A 397 N VAL A 342 SHEET 3 B 3 LEU A 403 LEU A 405 -1 O MET A 404 N PHE A 396 SHEET 1 C 2 LEU A 385 HIS A 387 0 SHEET 2 C 2 LEU A 411 LYS A 413 -1 O TRP A 412 N VAL A 386 SHEET 1 D 2 ARG A 417 PRO A 419 0 SHEET 2 D 2 THR A 437 THR A 439 -1 O ALA A 438 N GLY A 418 SSBOND 1 CYS A 458 CYS A 492 1555 1555 2.02 LINK O2A ATP A 600 MG MG A 602 1555 1555 1.96 LINK O1A ATP A 600 MG MG A 603 1555 1555 2.00 LINK O3G ATP A 600 MG MG A 603 1555 1555 2.07 LINK MG MG A 602 O HOH A 611 1555 1555 2.08 LINK MG MG A 602 O HOH A 612 1555 1555 2.09 LINK OD2 ASP A 393 MG MG A 603 1555 1555 2.11 LINK OD1 ASP A 407 MG MG A 602 1555 1555 2.12 LINK O2B ATP A 600 MG MG A 603 1555 1555 2.14 LINK MG MG A 602 O HOH A 644 1555 1555 2.16 LINK MG MG A 603 O HOH A 610 1555 1555 2.17 LINK MG MG A 602 O HOH A 608 1555 1555 2.17 LINK MG MG A 603 O HOH A 615 1555 1555 2.21 CISPEP 1 ALA A 176 GLY A 177 0 -4.26 CISPEP 2 SER A 322 PRO A 323 0 5.57 SITE 1 AC1 27 ARG A 241 GLY A 243 ASP A 244 ARG A 245 SITE 2 AC1 27 SER A 246 VAL A 248 ALA A 261 LYS A 263 SITE 3 AC1 27 MET A 337 PRO A 338 ALA A 340 ASP A 343 SITE 4 AC1 27 ASP A 393 PHE A 396 MG A 602 MG A 603 SITE 5 AC1 27 HOH A 608 HOH A 610 HOH A 611 HOH A 612 SITE 6 AC1 27 HOH A 615 HOH A 618 HOH A 627 HOH A 633 SITE 7 AC1 27 HOH A 644 HOH A 649 HOH A 782 SITE 1 AC2 9 LYS A 263 PHE A 265 LEU A 335 ASP A 407 SITE 2 AC2 9 HOH A 605 HOH A 611 HOH A 620 HOH A 625 SITE 3 AC2 9 HOH A 834 SITE 1 AC3 6 ASP A 407 ATP A 600 HOH A 608 HOH A 611 SITE 2 AC3 6 HOH A 612 HOH A 644 SITE 1 AC4 4 ASP A 393 ATP A 600 HOH A 610 HOH A 615 CRYST1 123.358 69.329 43.385 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008106 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014424 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023049 0.00000